Endocannabinoids and the gastrointestinal tract: what are the key questions?
about
TRP channels in neurogastroenterology: opportunities for therapeutic interventionCannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in miceInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceAlcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals.Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomitingCannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.A role for GPR55 in human placental venous endothelial cells.Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats.Molecular mechanisms of appetite regulation.The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat dietTranslational neuropharmacology: the use of human isolated gastrointestinal tissues.Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide.Role of cannabinoid receptors in the control of gastrointestinal motility and perception.Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation.Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.Rimonabant, gastrointestinal motility and obesity.Advances in the Physiology of GPR55 in the Central Nervous System.Cannabinoids and their actionsCannabinoids mediate opposing effects on inflammation-induced intestinal permeability.Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.Cannabinoids modulate cell survival in embryoid bodiesEndogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation
P2860
Q24618774-98E3879A-07B1-44A3-BCAB-E1F8FE07D2EDQ24645241-4676049F-6A27-4E69-9660-DD48FF4F17C8Q28258759-C4CD1933-2761-4BA0-A9DA-3C10A1141793Q33560137-14816A14-CEAD-4214-BB9C-1EB2BBEAE588Q34381296-AF9D41DC-2487-4823-89EC-83959C9DB739Q34547759-1067EDEB-58B0-47F0-900E-0E3D34F738DAQ35806135-D25A5D5D-6FAA-4FB1-B585-2C85614D4133Q36176468-FE8957BD-7CDD-492A-9A9D-9BB9833A6749Q36490110-82CD791E-77E4-40C8-AAE2-D2F0C413099BQ36510027-BE4E1297-4F70-4EC8-9A9F-63F1D165F6AFQ36603175-9A4FA081-0D00-435C-8598-02F521B15FBFQ36808188-D8466788-CD26-4EC5-89D2-B29EF74A5498Q36977483-C084958D-2976-4B2D-BFD1-0545AA67B9E6Q37143573-56E94DB6-35BC-49E1-8F9D-8A7A6429185DQ37345943-E06B9BD9-E285-4E44-AA38-5B568A2F7402Q37376946-010A8D22-08A3-4BCA-BAD7-9AF88E19C675Q37826693-7637C8E7-1173-47F4-8705-7DCF7C2DFACEQ38021639-F8AD53AE-1C00-4EF4-8B00-E7F342B1B9C4Q38085530-DED1C929-EABC-47CF-A955-EB7451821B6EQ38917434-A25180FB-A8D7-4405-AC0A-BCF8F82827EBQ39580210-8F12A4E3-143C-4373-B1C4-8491CA3B1D57Q41963239-A9EB3540-0163-468D-806C-2024B18C649AQ48540880-2E3B800B-A4B2-4F67-B275-07D58001D0A5Q57599535-BCF27835-4E97-4D10-82F0-260032B954E5Q58080090-EEC89A36-7C87-473A-BE76-1F105A845A15
P2860
Endocannabinoids and the gastrointestinal tract: what are the key questions?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Endocannabinoids and the gastrointestinal tract: what are the key questions?
@en
type
label
Endocannabinoids and the gastrointestinal tract: what are the key questions?
@en
prefLabel
Endocannabinoids and the gastrointestinal tract: what are the key questions?
@en
P2860
P356
P1476
Endocannabinoids and the gastrointestinal tract: what are the key questions?
@en
P2093
G J Sanger
P2860
P304
P356
10.1038/SJ.BJP.0707422
P407
P577
2007-09-03T00:00:00Z